Business Standard

Jhunjhunwala, shareholders question Fortis-Manipal deal over valuations

Analysts feel Fortis Healthcare share holders are at a disadvantage and deal valuations had been short of expectations

Graph
Premium

Ujjval Jauhari
Ace investor Rakesh Jhunjhunwala and many minority investors are said to be questioning the Fortis healthcare deal with Manipal Hospitals, as per news reports. A private equity firm has also been reported of having increased its stake in Fortis healthcare to attain extra voting rights of about 9.73 per cent and is said to be wooing some more minority investors including hedge funds to oppose the deal.

All this, however, is not surprising. The disappointment of the investors on Fortis-Manipal hospital deal was well evident from the day of announcement of the deal itself. Fortis healthcare (FHL) share prices had seen

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in